CorMedix (CRMD)
(Delayed Data from NSDQ)
$11.13 USD
-0.49 (-4.22%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $11.12 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, CorMedix Inc has a market cap of $910.31M, which represents its share price of $11.62 multiplied by its outstanding shares number of 78.34M. As a small-cap company, CRMD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CRMD 11.13 -0.49(-4.22%)
Will CRMD be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CRMD based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for CRMD
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down
CRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark
RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down
Other News for CRMD
20 Day Moving Average Support appears for CRMD after 4.22% move
Technical picture remains unchanged for CRMD after it rises 2.74% on October 30
CRMD Crosses Below Key Moving Average Level
Is CRMD signaling a buying opportunity? 20 Day Moving Average Support shows up after climbing 1.53%
CRMD Crossed Above 20 Day Moving Average on October 28